The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds
- PMID: 11483205
- DOI: 10.1016/s0161-5890(01)00050-5
The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds
Abstract
Unlike other immunoglobulin G (IgG) subclasses, IgG4 antibodies in plasma have been reported to be functionally monovalent. In a previous paper, we showed that the apparent monovalency of circulating IgG4 antibodies is caused by asymmetry of plasma IgG4-a large fraction has two antigen-binding sites resulting in bispecificity. We postulated that the generation of bispecific antibodies was caused by a post-secretion mechanism, involving the exchange of IgG4 half-molecules (i.e. one heavy and one light chain). This hypothesis was based on the observed instability of the inter-heavy chain disulfide bonds of IgG4. To investigate this instability, we constructed IgG4 mutants and analyzed the covalent interaction between the heavy chains by sodium dodecyl sulfate-poly acrylamide gel electrophoresis (SDS-PAGE) under non-reducing conditions. The mutation to serine of one of the hinge cysteines involved in the inter-heavy chain bond formation, Cys226, resulted in a more stable rather than a more labile inter-heavy chain linkage. Moreover, we confirmed that mutating the IgG4 hinge sequence Cys-Pro-Ser-Cys to the IgG1 hinge sequence Cys-Pro-Pro-Cys also markedly stabilizes the covalent interaction between the heavy-chains. These two observations suggested an explanation for the observed instability of the inter-heavy chain disulfide bonds: the formation of an alternative, intra-chain cystine. Obviously, this intra-chain cystine cannot be formed in the mutant where Cys226 is replaced by Ser, and cannot easily be formed in the mutant with the IgG1 hinge sequence (Cys-Pro-Pro-Cys) due to the restricted torsional freedom of prolines. We, therefore, postulate that the lack of a covalent heavy-chain interaction in a subpopulation of IgG4 reflects an equilibrium between inter- and intra-chain cystines. Based upon the published structure of the IgG4-related hinge-deleted IgG1 myeloma protein Mcg, we propose a model for the two forms of IgG4 and for the half-molecule exchange reaction, which might result in the formation of bispecific IgG4 antibodies.
Similar articles
-
Mechanistic insights into inter-chain disulfide bond reduction of IgG1 and IgG4 antibodies.Appl Microbiol Biotechnol. 2022 Feb;106(3):1057-1066. doi: 10.1007/s00253-022-11778-5. Epub 2022 Jan 24. Appl Microbiol Biotechnol. 2022. PMID: 35072737
-
Intrachain disulfide bond in the core hinge region of human IgG4.Protein Sci. 1997 Feb;6(2):407-15. doi: 10.1002/pro.5560060217. Protein Sci. 1997. PMID: 9041643 Free PMC article.
-
Fc-Fc interactions of human IgG4 require dissociation of heavy chains and are formed predominantly by the intra-chain hinge isomer.Mol Immunol. 2013 Jan;53(1-2):35-42. doi: 10.1016/j.molimm.2012.06.012. Epub 2012 Jul 10. Mol Immunol. 2013. PMID: 22784992
-
IgG4 breaking the rules.Immunology. 2002 Jan;105(1):9-19. doi: 10.1046/j.0019-2805.2001.01341.x. Immunology. 2002. PMID: 11849310 Free PMC article. Review.
-
Enlarging the repertoire of therapeutic monoclonal antibodies platforms: domesticating half molecule exchange to produce stable IgG4 and IgG1 bispecific antibodies.Curr Opin Biotechnol. 2014 Dec;30:225-9. doi: 10.1016/j.copbio.2014.09.001. Epub 2014 Sep 23. Curr Opin Biotechnol. 2014. PMID: 25254943 Review.
Cited by
-
Developability considerations for bispecific and multispecific antibodies.MAbs. 2024 Jan-Dec;16(1):2394229. doi: 10.1080/19420862.2024.2394229. Epub 2024 Aug 27. MAbs. 2024. PMID: 39189686 Free PMC article. Review.
-
Mechanistic insights into inter-chain disulfide bond reduction of IgG1 and IgG4 antibodies.Appl Microbiol Biotechnol. 2022 Feb;106(3):1057-1066. doi: 10.1007/s00253-022-11778-5. Epub 2022 Jan 24. Appl Microbiol Biotechnol. 2022. PMID: 35072737
-
R409K mutation prevents acid-induced aggregation of human IgG4.PLoS One. 2020 Mar 17;15(3):e0229027. doi: 10.1371/journal.pone.0229027. eCollection 2020. PLoS One. 2020. PMID: 32182240 Free PMC article.
-
Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo.Nat Biotechnol. 2009 Aug;27(8):767-71. doi: 10.1038/nbt.1553. Epub 2009 Jul 20. Nat Biotechnol. 2009. PMID: 19620983
-
Characterization of 405B8H3(D-E), a newly engineered high affinity chimeric LAG-3 antibody with potent antitumor activity.FEBS Open Bio. 2023 Jul;13(7):1253-1265. doi: 10.1002/2211-5463.13648. Epub 2023 Jun 11. FEBS Open Bio. 2023. PMID: 37302810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources